Amylyx Pharmaceuticals Completes $575 Million Upsized Public Offering of Common Stock

▤ Summary

Amylyx Pharmaceuticals completed an upsized public offering of common stock and raised $575 million. The company increased the size of the offering from its original plan. This transaction strengthens its cash position and supports its ongoing operations and pipeline development. The event is primarily a financing update rather than a product, acquisition, or people announcement.

$ Funding

▦ Linked Companies